advantages of autogenous bone grafts without the disadvantages. A new ultraporous β-TCP construct, engineered using solution-derived nano-particle technology, may prove to be an ideal carrier for BMA in such a composite. The unique, interconnected macroporosity, mesoporosity, and microporosity of this synthetic cancellous bone void filler allows it to wick in cells and nutrients via enhanced capillarity. Preliminary canine data support this expectation, demonstrating bone formation that suggests good penetration of cells and nutrients. These results suggest that BMA cells, absorbed into such a scaffold, may remain viable, thereby potentially making such a composite a true synthetic replacement for autogenous cancellous bone.
Keywords Bone remodeling · Bone biology · Bone marrow aspirate · Cancellous bone · β-TCP to regenerate and heal. For a bone graft to be successful, three processes that mimic natural events in cancellous bone must take place [2] :
1. Osteoconduction: the apposition of growing bone to the three-dimensional surface of a suitable scaffold provided by the graft 2. Osteoinduction: the biologically mediated recruitment and differentiation of cell types essential to bone formation 3. Osteogenesis: the process of bone formation through cellular activity, which, in turn, is dependent upon the presence of osteoprogenitor stem cells
Orthopedists currently use a variety of materials that enhance these three processes to different degrees (Table 1) . [1, 2] .
Autograft
Autogenous bone is generally considered the gold-standard graft material [18] . The unique advantage of the autograft is that it contains viable osteoblasts and osteogenic precursor cells that can contribute to the formation of new bone [1] . Unfortunately, this advantage is not fully realized in practice because graft processing results in the death of most of the cellular elements [17] . Those cells that survive must initially receive their oxygen via diffusion; thus considerable anoxic cell death probably occurs before sufficient vascularization has permeated the graft. Revascularization into the internal regions of the autograft is slow and incomplete; the process can be inhibited by fibrin clotting in the autograft and by the packing procedure used to place the graft into the surgical site. Most of the osteogenic cells that repopulate the graft are thought to be extrinsic cells that migrate, along with S142 osteoinductive growth factors, into the graft from the surrounding bone defect site. The repopulation of the bone mineral structure by extrinsic cells drives the healing process, as the trabecular structure of natural cancellous bone serves as the scaffold for cell-mediated resorption and concurrent rebuilding of new bone ( Fig. 1 ).
Complications of iliac crest autograft procurement
Autograft procurement is associated with significant morbidity [17] . An early retrospective study of donor-site morbidity reviewed 243 bone grafts, 90% of which were from the iliac crest [21] . Complications were found to occur at an overall rate of 29.2%. Later studies have reported donor-site complication rates ranging from 4% to 49% [7] . Major complications, which have been reported at rates from 0.7% to 25% [17] , include infection, prolonged wound drainage, large hematomas, reoperation, complete pelvic ring failure, enterocutaneous fistula, pain lasting longer than 6 months, sensory loss, subluxation, gait disturbances, sacroiliac joint destabilization, herniation of muscle and abdominal contents, pelvic or iliac fracture, and heterotopic bone formation [4, 7, 8] Even in the absence of "avoidable" complications, unavoidable problems are associated with autograft procurement. These include limited availability, high cost, temporary disruption of donor-site bone structure, increased operative time, and significantly increased operative blood loss [1, 17, 19] .
Autograft alternatives

Allografts
Allografts are bone grafts harvested from another member of the same species. They are processed to remove cells and debris in order to minimize their infectious and immunogenic potential. As a result of this processing, allografts do not contain living cells and are not osteogenic [17] . However, they generally have excellent osteoconductive properties and can exert a somewhat osteoinductive effect on cell in-migration and differentiation.
Xenografts
Because of their immunogenicity, xenograft preparations harvested from another species have generally been impractical for clinical use. To guarantee viral inactivation, not only cells but all proteins must be removed, thus eliminating both osteogenic and osteoinductive potential.
Synthetic bone grafts
By sidestepping both the avoidable and unavoidable problems of autograft use, synthetic bone graft materials have the potential to greatly expand orthopedic options. Historically, the materials used have been ceramics of hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ), tricalcium phosphate (Ca 3 (PO 4 ) 2 ), or combinations of the two. When used alone for grafting, synthetic grafting materials function solely as osteoconductive scaffolding for new bone growth and as bridges to the host bone. The scaffold is then removed by a combination of dissolution and phagocytosis (cell-mediated resorption). Since 1982, β-TCP constructs have been used as synthetic bone void fillers in dentistry and orthopedics without adverse events [6, 13] . Porous β-TCP synthetic cancellous bone void fillers should resemble human cancellous bone in structure and composition. Generally, β-TCPs contain approximately 39% calcium and 20% phosphorus by weight, similar to natural mineral content in bone [12] .
Vitoss synthetic cancellous bone void filler differs from previously used β-TCP constructs in that it is characterized by nano-sized particles and an extensive pore size distribution (Fig. 2) . Vitoss is a porous, low-density construct prepared by lightly fusing particles of β-TCP that average approximately 1-2 µm in diameter. The use of nano-sized β-TCP primary particles increases the microporosity of the structure, resulting in a scaffold of approximately 90% interconnected void space, with pores ranging in size from less than 1 µm to 1000 µm. This large increase in interconnected porosity, relative to other β-TCP constructs, potentially permits a more continuous supply of nutrients, more extensive cellular and tissue ingrowth into the scaffold, and enhanced revascularization, allowing bone repair to take place faster and more completely. In vivo studies have shown that progressively smaller particles improve osteoconductive performance [11] . Since more of its surface area is exposed to the bio-S143 Fig. 2 Micron-sized particles of Vitoss as visualized by scanning electron microscopy. The particles are 1-2 µm. These polycrystalline particles are comprised of crystallites that range from 70 to 100 nm in diameter by X-ray diffraction (XRD) methods logic milieu, the scaffold may be resorbed at a higher rate than are denser forms of β-TCP. In fact, nanometer-sized crystallites are small enough for the body to digest with normal cellular activity; this is crucial for resorption during bone remodeling.
Animal Study
A canine study was undertaken to assess the efficacy of Vitoss synthetic cancellous bone void filler. Blocks of Vitoss were used in the repair of cylindrical metaphyseal defects measuring 10 mm×25 mm in canine humeri. Bone ingrowth and scaffold resorption were quantified using standard histomorphometric techniques for specimens examined up to 1 year postimplantation. As early as 3 weeks, Vitoss showed resorption throughout the defect site and some immature bone formation evenly throughout as well (Fig. 3) . Remodeling was essentially complete in 6-12 weeks, with bone density in the normal range and with the scaffold almost completely resorbed by the end of that period (Fig. 4) . By 24 weeks, the implant trabecular orientation approximated the normal stress patterns of adjacent bone. Histologically and radiographically, the bone within the defects was virtually indistinguishable from the surrounding bone at the 12-, 24-, and 52-week follow-ups. The stress-strain curve of Vitoss is nearly identical to bone at 24 weeks and at 52 weeks (Fig. 5) , and X-ray diffraction (XRD) data confirms a 95% match to normal bone at 1 year.
These results indicated that Vitoss might perform better in a number of ways than previously studied ceramics. First, using traditional synthetics, bone formation and osteoconduction took longer and was most prevalent at the periphery of the defect [3, 11] . The only new bone that formed as a result of the osteoconductivity of the porous ceramic was an extension of the outgrowth from the cut ends of the host bone [3] . In contrast, one of the striking things about Vitoss is the pattern of resorption and osteogenesis throughout the implant site. Second, whereas Vitoss was almost completely resorbed in 12 weeks, a ceramic composed of hydroxyapatite and traditional β-TCP showed essentially no resorption over the first 16 weeks after implantation [3] . Third, despite very high porosity, Vitoss synthetic cancellous bone void filler is easily manipulated at surgery, either sculpted as blocks or poured as morsels. In contrast, hydroxyapatite bone substitute was not ideal for the treatment of segmental defects because of its incompressible nature and lack of completely interconnected pores [3] .
Composite grafts
A composite graft can be defined as any combination of materials that includes an osteoconductive matrix, an osteogenic material, and an osteoinductive material, thus fulfilling the three requirements for a successful bone graft. Osteogenic and osteoinductive bone marrow aspirate
Background
If the osteoconductive ceramic scaffold is seeded with bone progenitor cells, the composite graft should become osteogenic and osteoinductive as well, in effect providing a competitive alternative to autografts. The hypothesis is that such a strategy accelerates healing by minimizing the immediate need for chemotaxis and massive proliferation of osteoblast progenitor cells into the defect. With years of experience and wide clinical use, bone marrow aspirate (BMA) is the most practical source of bone progenitor cells [14] . Aspiration of bone marrow cells is a relatively benign procedure, and a number of previous studies demonstrate the positive effect of BMA on bone formation both in vitro and in vivo [5] . Osteoprogenitor stem cells are prevalent in BMA and are able to differentiate into five other cell types (osteoblasts, osteoclasts, adipose cells, chondroblasts, and fibroblasts) and modify their morphologic/functional attributes as needed [15] . This osteogenic potential was maintained as the cells were expanded in culture and enriched for grafting [9] .
Bone marrow aspirate and bone composites
Autologous bone marrow aspirated from the iliac crest had a beneficial effect upon osteogenesis when implanted with xenograft bone graft material (Kiel bone) [16] , and the addition of BMA to autograft iliac crest bone graft facilitated greater bone formation and successful fusion in a rabbit posterolateral spine fusion model [5] . Furthermore, it was found that xenograft bone and other bone substitutes could be rendered osteogenic by combining them with fresh BMA [20] .
Bone marrow aspirate and synthetic composites
A number of studies have used composites of bone marrow and synthetics for bone grafting [3, 10, 11] . Studies on the healing of canine femoral defects with implanted calcium phosphate cylinders loaded with cultured autologous mesenchymal stem cells showed that the addition of such cells augmented the development of new periosteal bone around the implants [3] . Similarly, hydroxyapatite ceramic (HAC) combined with bone marrow stromal cell populations resulted in far more extensive bone defect repair over a 2-month period [11] . However, in both of these studies, even in the cellloaded scaffold, a higher concentration of new bone began in the periphery. The authors speculate that this is due to better survival of loaded cells within the outermost portions of the HAC cylinder, the area expected to be vascularized faster and more efficiently than more internal regions. They note that this may be related to the design and structure of the implant device. The animal study with Vitoss, which showed bone formation throughout with an ultraporous β-TCP scaffold, would support this hypothesis.
Bone marrow aspirate and ultraporous β-tricalcium phosphate synthetic cancellous bone void filler composite
The newest generation of ultraporous β-TCP constructs have unique biomechanical properties that may make them particularly well suited for use with BMA in a composite graft. The extremely broad range of pore sizes (<1 µm to 1000 µm) and the sponge-like interconnected microporosity endow the scaffold with excellent wicking and hydrophilic properties. These attributes allow the migration of bone-forming cells, phagocytic cells, growth factors, and nutrients into the scaffold, enhancing the processes of new bone development and scaffold resorption. The unique structure of β-TCP would, therefore, be conducive to rapid vascularization and nourishment of the seeded bone marrow, including bone-forming cells. In this respect, a β-TCP/BMA composite may even be superior to the autograft, in which most cellular elements suffer from anoxic cell death due to delayed revascularization (Fig. 1) . One of the striking features of grafting with ultraporous β-TCP, compared with using other synthetic constructs, is the formation of bone that occurs throughout the implant, suggesting good penetration of cells and nutrients (Fig. 6 ). 
Conclusion
Synthetic bone substitutes have the potential to increase graft availability, to eliminate autograft procurement morbidity, and to avoid the risk of disease transmission associated with allografts and xenografts. Vitoss synthetic cancellous bone void filler, an ultraporous construct (90% interconnecting, multidirectional pores) of pure β-TCP, is a new bone graft synthetic based on proprietary solutionderived nanoparticle construction. Interconnected microporosity may accelerate remodeling by facilitating in-migration and retention of osteogenic cells and nutrients via enhanced capillarity. Preliminary canine data demonstrate significant bone formation and resorption, supporting this hypothesis. Thus Vitoss would seem a logical delivery vehicle for BMA-derived osteoinductive growth factors and osteogenic bone precursor cells. Studies evaluating an ultraporous β-TCP/BMA composite as a true autogenous bone graft substitute are under way.
